Overview Irritation and Sensitization Study of HP-5000 Topical System Status: Recruiting Trial end date: 2022-05-01 Target enrollment: Participant gender: Summary This study will assess skin irritation and sensitization for HP-5000 patch in healthy subjects. Phase: Phase 1 Details Lead Sponsor: Noven Pharmaceuticals, Inc.